We're exhibiting! CITI Program is excited to attend MAGI 2026. Visit us to learn more about our clinical research course offerings and training solutions. See you in Chicago!
#MAGI2026 #ClinicalResearch

Explanation of the Revised NIH Definition of a Clinical Trial By aligning the definition of “intervention” with the Common Rule and retaining key elements of the NIH clinical trial definition, NIH simplifies compliance.

NIH continues to clarify its clinical trial definition and identification to support transparency and consistency in human research.
https://post.citiprogram.org/4sPVsgZ
#ClinicalTrials #NIH #HumanSubjectsResearch

National Public Health Week 2026 honors public health professionals and the ethical, science‑based systems that protect communities, and challenges us to keep strengthening the standards that support a healthier future. #NPHW

CITI Program is excited to exhibit at the 2026 @aeraedresearch.bsky.social Annual Meeting! Come speak with us to learn about our higher education training solutions and content offerings. We look forward to meeting you in Los Angeles!
#AERA2026 #HigherEducation

Software Development Ethics | CITI Program Software Development Ethics A comprehensive introduction to ethical principles, regulations, and responsible practices that guide software and technology professionals throughout the software development lifecycle. View this course at CITI Program.

Our new course, "Software Development Ethics," covers ethical principles, regulations, and responsible practices for the software development lifecycle. You can now add this course to your organization's subscription.
https://post.citiprogram.org/3PKcKgR
#SoftwareDevelopment #TechnologyEthics

Available Webinar Registrations | CITI Program Register for upcoming webinars covering a variety of research, higher education, healthcare, technology, and safety topics.

Register Now for Free! Our live webinar, "The Regulatory Landscape and Practical Challenges in Cellular Therapy," will focus on how human cells, tissues, or cellular and tissue-based products are regulated under 21 CFR 1271.
https://post.citiprogram.org/4dSRS0L
#CellularTherapy

Join us for a Q&A session! What navigation skills are most important for researchers working in the field?
Submit your answers in the comments.
Explore our webinar, "Field Research Navigation Essential Skills: Map, Compass, and GPS," to learn more: https://post.citiprogram.org/4caRGIU
#FieldResearch

Listen now! On Research Podcast Episode 15: Rethinking Child Assent Practices
This episode discusses rethinking child assent beyond procedural compliance.
https://post.citiprogram.org/417NLq7
#ChildAssent #ResearchCompliance

What CITI Program is Reading on April 1, 2026 This week CITI Program is reading about FDA efforts to decrease animal testing, healthcare billing fraud, compliance with ICH E6 in the UK, and more.

This week's titles include:
•NIH grant terminations affected women scientists more than men, study finds
•AI algorithms can become ‘agents of chaos’
•Healthcare billing fraud: 10 recent cases
See this week's complete list now.
https://post.citiprogram.org/4dFQY83
#GrantTerminations #AI #Healthcare

Join us for a Q&A session! What is a Research Integrity Standing Committee, and how is it different from ad hoc committees?
Explore our webinar, "The Essential Guide to Forming a Research Integrity Standing Committee," to learn more: https://post.citiprogram.org/41y0McG
#ResearchIntegrity #RISC

Visit CITI Program at this year's ACPA Annual Convention! Our team is ready to answer any questions you have regarding our higher education course offerings. Find us at booth # 12 and don't forget to grab some fun swag while you're there!
#ACPA26 #HigherEducation

Happy National Doctors' Day to the physicians who drive progress every day, advancing research, strengthening patient care, and upholding the standards that keep healthcare ethical and trusted. Thank you for all you do.
#NationalDoctorsDay #DoctorsDay #Healthcare

Listen now! On Campus Podcast Episode 3: Gen Z Expectations for College and the Future of Higher Education
This episode discusses what Gen Z students truly want from higher education.
https://post.citiprogram.org/4bWYsAM
#GenZ #HigherEducation

Check out the upcoming conferences that CITI Program will be attending in April. We hope to see you there—let us know if you'll be joining us!
#Conference #Research #HigherEducation

Join us for a Q&A session! What makes research with children ethically different from research with adults?
Submit your answers in the comments.
Explore our webinar, "Risk Mitigation and Support for Younger Study Populations," to learn more: https://post.citiprogram.org/4dJOUeX
#ResearchEthics

NIH Seeks Input on Resources for Implantable Device Trials In March 2026, the NIH released two draft resources to improve the design, conduct, and communication with participants in implantable device trials.

In March 2026, the National Institutes of Health (NIH) released two draft resources to improve the design, conduct, and communication with participants in implantable device trials.
https://post.citiprogram.org/4lPLM3e
#NIH #ImplantableDevices

We're exhibiting! Visit CITI Program at the ACPA 2026 Annual Convention to learn about our higher education training solutions, course offerings, and more. We can't wait to meet you. See you in Baltimore!
#ACPA26 #HigherEducation

Research Ethics for All (RE4All) | CITI Program Research Ethics for All (RE4All) Provides community research partners with disability-accessible education on ethical issues in social and behavioral research. View this course at CITI Program.

Our new course, "Research Ethics for All (RE4All)," provides community research partners with disability-accessible education on ethical issues in social and behavioral research. You can now add this course to your organization's subscription.
https://post.citiprogram.org/3NG9X7M
#ResearchEthics

It’s National #ScienceAppreciationDay! March 26 celebrates all of the good that scientific questioning, research, and advancement have brought to our quality of life. Thank you to workers in all fields of science, including research, medicine, and technology.

Join us for a Q&A session! What is participatory science, and why does it raise unique ethical questions?
Submit your answers in the comments.
Explore our webinar, "Participatory Science and the Institutional Review Board," to learn more: https://post.citiprogram.org/4uIoz77
#ParticipatoryScience

CITI Program Media Playlist for March 25, 2026 This week's playlist includes content about ethical tech as a competitive advantage, the rise of deepfakes, machine learning, and more.

This week's playlist includes content about ethical tech as a competitive advantage, the rise of deepfakes, machine learning, and more. View the complete playlist now.
https://post.citiprogram.org/4da1cNv
#TechEthics #Deepfakes #MachineLearning

Join us for a Q&A session! What’s a practical first step for organizations trying to comply with the DOJ Bulk Data Rule?
Submit your answers in the comments.
Explore our webinar, "DOJ Bulk Data Transfer Rule," to learn more: https://post.citiprogram.org/4d87Eoo
#DOJ #DataManagement

Reminder to join CITI Program for our Webinar Symposium tomorrow, March 24! The symposium will showcase five prior webinars delivered in CITI Replay format. Visit our registration page to sign up.
https://post.citiprogram.org/4t1BP5d
#Webinar #Research #Science #AI

RCR Research Security Training | CITI Program RCR Research Security Training Serves as research security training designed to augment RECR/RCR training. View this course at CITI Program.

Our new course, "RCR Research Security Training," serves as research security training designed to augment RECR/RCR training. You can now add this course to your organization's subscription as part of our "Research Security" series.
https://post.citiprogram.org/4sZNJg6
#RECR #RCR #ResearchSecurity

What CITI Program is Reading on March 19, 2026 This week CITI Program is reading about new UK clinical trials regulations, using AI for drug advertising, the misuse of children's genetic data, & more.

This week's titles include:
•New UK clinical trials regulations: what you need to know
•Institutional Review Board Obligations Regarding Study Funding Sufficiency
•Experts offer tips for using AI for drug advertising and promotion
https://post.citiprogram.org/41g1ZVU
#ClinicalTrials #IRB #AI

Join us for a Q&A session! How can generative AI be useful during early research design?
Submit your answers in the comments.
Explore our webinar, "Generative Artificial Intelligence in Research Design," to learn more: https://post.citiprogram.org/47QoEf9
#GenAI #GenerativeAI #ResearchDesign

CITI Program Funding Finds on March 17, 2026 This month, CITI Program is sharing opportunities from The Zuckerman STEM Leadership Program, NLR, Grants.gov, and more.

This month's opportunities include:
•Zuckerman Postdoctoral Scholars Program
•Director's Postdoctoral Fellowship
•Innovative Research in Cancer Nanotechnology
See this month's complete list now.
https://post.citiprogram.org/4sfRJsL
#Postdoc #STEM #Nanotechnology #CancerResearch

How does informed consent work when focus groups involve Indigenous or community-based populations?
Submit your answers in the comments.
Explore our webinar, "Ethical Research Relationships: IRBs & Focus Groups," to learn more: https://post.citiprogram.org/4bu1bBs
#ResearchEthics #IRB #FocusGroups

CITI Program is excited to exhibit at Higher Learning 2026! Be sure to visit us to learn about our higher education training solutions and course offerings. See you in Chicago!
#HigherLearning2026 #HigherEducation

FDA Launches New Adverse Event Look-Up Tool FDA launched a new unified platform for analyzing adverse event reports. This platform — called the FDA Adverse Event Monitoring System (AEMS) — represents a major achievement in the agency’s mission to modernize and provide radical transparency into the safety of regulated products.

The FDA launched a new unified platform for analyzing adverse event reports. This platform represents a major achievement in the agency’s mission to modernize and provide radical transparency into the safety of regulated products.
https://post.citiprogram.org/3NBKUTd
#FDA #AdverseEvents